Heights Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GenSight Biologics Announces a Successful Offering for an Amount Over €9 2 Million

GenSight Biologics shares resume trading today Over €9.2 million offering of ABSA composed of a reserved offering aimed at specialized investors and a private placement More than 50% of the.

South africaFrance generalUnited statesSaint antoineBpifrance financementGensight biologicsGensight biologics euronextLaurence rodriguezEuropean parliamentArmistice capital master fund ltdGoldman sachs group incCompany board of directorsEuropean unionRegulatory newsSight biologicsOffering price

Claranova: A new financial dynamic -April 02, 2024 at 02:16 am EDT

Refinancing the OCEANE debt and strengthening the cash position Signature of a €108m bullet loan agreement .

United statesHogan lovellsPierre cesariniGarnier coComposition of the groupClaranova groupClaranova developmentRegulatory newsCheyne capital managementHeights capitalNorth americaGross debtHeights capital management

Claranova: A new financial dynamic

Claranova: A new financial dynamic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPierre cesariniHogan lovellsComposition of the groupGarnier coClaranova developmentClaranova groupCheyne capital managementHeights capitalNorth americaGross debtHeights capital management

Crossject advances in its U S Strategy and reports Financial Results for 2023

Crossject advances in its U S Strategy and reports Financial Results for 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

France generalNew zealandUnited statesNatasha drapeauPatrick alexandreDaniel teperPhilippe monnotSophie baumontAdministration for strategic preparednessHeights capital management incUs biomedical advanced researchDepartment of healthCohesion bureauDevelopment authorityFrench ministry of armed forces ministDrug administration

GenSight Biologics announces completion of a €5 million capital increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital

GenSight Biologics announces completion of a €5 million capital increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaFrance generalAutorisation temporaireGuillaume van renterghemGensight biologics euronextGensight biologicsIvan tortetLaurence rodriguezEuropean parliamentEuropean investment bankCompany board of directorsInvestments incSight biologicsSofinnova partnersHeights capital